Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatesh Muthukumar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ACS Omega|January 5, 2026
Molecular Frameworks for ERK1/2 Inhibition: Lessons from Synthetic and SAR ExplorationsVenkatesh Muthukumar, Anushka Vashishth, Subashani Maniam, et al.
Bioorganic Chemistry|December 18, 2024
Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cellsMoumita Ghosh Chowdhury, Saumya Kapoor, Venkatesh Muthukumar, et al.
RSC Medicinal Chemistry|May 11, 2026
A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: <i>in silico</i> design, synthesis, biological assessment and binding interaction analysisSamima Khatun, Venkatesh Muthukumar, Ambati Himaja, et al.
Journal of Medicinal Chemistry|October 1, 2025
Thiazole-Based Tumor Pyruvate Kinase M2 Inhibitors: A Paradigm-Shifting Therapeutic Strategy Targeting Metabolic and Microbial Synergy in Colorectal CancerMoumita Ghosh Chowdhury, Aditya A Singh, Medha Bhattacharyya, et al.
Macromolecular Bioscience|July 8, 2026
Biogenic Silver Nanoparticles-Reinforced Carboxymethyl Chitosan-Based Modified Gauze as Multifaceted Wound Care MaterialVictor Roychowdhury, Venkatesh Muthukumar, Soumita Sarkar, et al.
RSC Medicinal Chemistry|August 16, 2024
Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivativesAsmita Choithramani, Rudradip Das, Gourav Bothra, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ACS Omega|January 5, 2026
Molecular Frameworks for ERK1/2 Inhibition: Lessons from Synthetic and SAR ExplorationsVenkatesh Muthukumar, Anushka Vashishth, Subashani Maniam, et al.
Bioorganic Chemistry|December 18, 2024
Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cellsMoumita Ghosh Chowdhury, Saumya Kapoor, Venkatesh Muthukumar, et al.
RSC Medicinal Chemistry|May 11, 2026
A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: <i>in silico</i> design, synthesis, biological assessment and binding interaction analysisSamima Khatun, Venkatesh Muthukumar, Ambati Himaja, et al.
Journal of Medicinal Chemistry|October 1, 2025
Thiazole-Based Tumor Pyruvate Kinase M2 Inhibitors: A Paradigm-Shifting Therapeutic Strategy Targeting Metabolic and Microbial Synergy in Colorectal CancerMoumita Ghosh Chowdhury, Aditya A Singh, Medha Bhattacharyya, et al.
Macromolecular Bioscience|July 8, 2026
Biogenic Silver Nanoparticles-Reinforced Carboxymethyl Chitosan-Based Modified Gauze as Multifaceted Wound Care MaterialVictor Roychowdhury, Venkatesh Muthukumar, Soumita Sarkar, et al.
RSC Medicinal Chemistry|August 16, 2024
Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivativesAsmita Choithramani, Rudradip Das, Gourav Bothra, et al.
Pageof 1